• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨一种替代的通用模型,用于预测生理应激期间的药代动力学变化。

Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress.

机构信息

Defence Research and Development Canada-Toronto, Toronto, Ontario, Canada.

出版信息

J Clin Pharmacol. 2013 Oct;53(10):1048-57. doi: 10.1002/jcph.131. Epub 2013 Jul 12.

DOI:10.1002/jcph.131
PMID:23852614
Abstract

Physiologically based pharmacokinetic models were developed using MATLAB Simulink® and PK-Sim®. We compared the capability and usefulness of these two models by simulating pharmacokinetic changes of midazolam under exercise and heat stress to verify the usefulness of MATLAB Simulink® as a generic PBPK modeling software. Although both models show good agreement with experimental data obtained under resting condition, their predictions of pharmacokinetics changes are less accurate in the stressful conditions. However, MATLAB Simulink® may be more flexible to include physiologically based processes such as oral absorption and simulate various stress parameters such as stress intensity, duration and timing of drug administration to improve model performance. Further work will be conducted to modify algorithms in our generic model developed using MATLAB Simulink® and to investigate pharmacokinetics under other physiological stress such as trauma.

摘要

我们使用 MATLAB Simulink® 和 PK-Sim® 开发了基于生理学的药代动力学模型。我们通过模拟咪达唑仑在运动和热应激下的药代动力学变化来比较这两种模型的能力和有用性,以验证 MATLAB Simulink® 作为通用 PBPK 建模软件的有用性。虽然这两种模型在休息状态下与实验数据都吻合良好,但在应激状态下,它们对药代动力学变化的预测准确性较低。然而,MATLAB Simulink® 可能更灵活,可以纳入基于生理学的过程,如口服吸收,并模拟各种应激参数,如应激强度、药物给药的持续时间和时间,以提高模型性能。我们将进一步修改使用 MATLAB Simulink® 开发的通用模型中的算法,并研究其他生理应激(如创伤)下的药代动力学。

相似文献

1
Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress.探讨一种替代的通用模型,用于预测生理应激期间的药代动力学变化。
J Clin Pharmacol. 2013 Oct;53(10):1048-57. doi: 10.1002/jcph.131. Epub 2013 Jul 12.
2
A physiologically based pharmacokinetics model for melatonin--effects of light and routes of administration.褪黑素的生理药代动力学模型——光照和给药途径的影响。
Int J Pharm. 2013 Dec 15;458(1):156-68. doi: 10.1016/j.ijpharm.2013.09.033. Epub 2013 Oct 11.
3
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.一项安慰剂和咪达唑仑对照的 I 期单递增剂量研究,评估雷米唑仑(CNS 7056)的安全性、药代动力学和药效学:第二部分。群体药代动力学和药效学建模与模拟。
Anesth Analg. 2012 Aug;115(2):284-96. doi: 10.1213/ANE.0b013e318241f68a. Epub 2012 Jan 16.
4
Evaluating a physiologically based pharmacokinetic model for predicting the pharmacokinetics of midazolam in Chinese after oral administration.评估一种基于生理的药代动力学模型,用于预测口服给药后咪达唑仑在中国人群中的药代动力学。
Acta Pharmacol Sin. 2016 Feb;37(2):276-84. doi: 10.1038/aps.2015.122. Epub 2015 Nov 23.
5
Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.运用基于生理的药代动力学模型方法模拟热和运动应激下的药物差异药代动力学。
Can J Physiol Pharmacol. 2011 May;89(5):365-82. doi: 10.1139/y11-030. Epub 2011 May 31.
6
Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach.根据稀疏采样方法,使用贝叶斯药代动力学软件(PKS)评估重症监护患者咪达唑仑浓度及药代动力学参数的估算情况。
J Pharm Pharmacol. 2003 Jun;55(6):765-71. doi: 10.1211/002235703765951366.
7
Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.溶出度整合到基于生理的药代动力学模型中 III:PK-Sim®。
J Pharm Pharmacol. 2012 Jul;64(7):997-1007. doi: 10.1111/j.2042-7158.2012.01534.x. Epub 2012 May 16.
8
A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.一种半生理基于药代动力学模型,用于描述机制基自动抑制作用,以预测维拉帕米及其代谢物去甲维拉帕米在人体中的立体选择性药代动力学。
Eur J Pharm Sci. 2013 Nov 20;50(3-4):290-302. doi: 10.1016/j.ejps.2013.07.012. Epub 2013 Jul 31.
9
A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration.咪达唑仑在犬体内的药代动力学研究:滴鼻给药与雾化器给药对比
Pediatr Dent. 1998 Sep-Oct;20(5):321-6.
10
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.一项安慰剂和咪达唑仑对照的 I 期单递增剂量研究,评估 remimazolam(CNS 7056)的安全性、药代动力学和药效学:第 I 部分。安全性、疗效和基本药代动力学。
Anesth Analg. 2012 Aug;115(2):274-83. doi: 10.1213/ANE.0b013e31823f0c28. Epub 2011 Dec 20.